BACKGROUND & AIMS: There are few well-designed studies evaluating the effect of oral nutrition supplements in patients with cancer cachexia. The aim of this study, in a posthoc analysis, was to examine the effect of dietary compliance on intake and body composition in patients with unresectable pancreatic cancer. METHODS:Two hundred patients were randomised to receive 2 cans/day of a protein and energy dense, oral nutrition supplement+/-n-3 fatty acids in an international, multi-centre randomised trial over 8 weeks. Dietary compliance was defined a priori as consumption of a minimum of 1.5 cans/day of either supplement. Body composition, dietary intake and quality of life were measured at baseline, 4 and 8 weeks. RESULTS: On average, there were significant differences in energy intake (501 kcal), protein intake (25.4 g) and weight (1.7 kg) between patients who were compliant with the nutrition prescription compared to noncompliant patients controlling for n-3 fatty acid randomisation, baseline weight and quality of life. Over the 8-week period, there was significant improvement in weight only. There was no significant difference in the energy intake from meals of the total group over the 8 weeks. CONCLUSIONS: Compliance with the prescription of 1.5 cans of a protein and energy dense, oral nutrition supplement +/-n-3fatty acids improved nutrition related outcomes in untreated pancreatic cancer patients. This level of supplement intake does not inhibit meal intake.
RCT Entities:
BACKGROUND & AIMS: There are few well-designed studies evaluating the effect of oral nutrition supplements in patients with cancer cachexia. The aim of this study, in a posthoc analysis, was to examine the effect of dietary compliance on intake and body composition in patients with unresectable pancreatic cancer. METHODS: Two hundred patients were randomised to receive 2 cans/day of a protein and energy dense, oral nutrition supplement+/-n-3 fatty acids in an international, multi-centre randomised trial over 8 weeks. Dietary compliance was defined a priori as consumption of a minimum of 1.5 cans/day of either supplement. Body composition, dietary intake and quality of life were measured at baseline, 4 and 8 weeks. RESULTS: On average, there were significant differences in energy intake (501 kcal), protein intake (25.4 g) and weight (1.7 kg) between patients who were compliant with the nutrition prescription compared to noncompliant patients controlling for n-3 fatty acid randomisation, baseline weight and quality of life. Over the 8-week period, there was significant improvement in weight only. There was no significant difference in the energy intake from meals of the total group over the 8 weeks. CONCLUSIONS: Compliance with the prescription of 1.5 cans of a protein and energy dense, oral nutrition supplement +/-n-3 fatty acids improved nutrition related outcomes in untreated pancreatic cancerpatients. This level of supplement intake does not inhibit meal intake.
Authors: Mohammad H Jamal; Suhail A Doi; Eve Simoneau; Jad Abou Khalil; Mazen Hassanain; Prosanto Chaudhury; Jean Tchervenkov; Peter Metrakos; Jeffrey S Barkun Journal: HPB (Oxford) Date: 2010-10 Impact factor: 3.647
Authors: Honor A Blackwood; Charlie C Hall; Trude R Balstad; Tora S Solheim; Marie Fallon; Erna Haraldsdottir; Barry J Laird Journal: Support Care Cancer Date: 2019-07-29 Impact factor: 3.603
Authors: Simone Gärtner; Janine Krüger; Ali A Aghdassi; Antje Steveling; Peter Simon; Markus M Lerch; Julia Mayerle Journal: Gastrointest Tumors Date: 2016-01-08
Authors: Jane A Read; Philip J Beale; Dianne H Volker; Narelle Smith; Annabel Childs; Stephen J Clarke Journal: Support Care Cancer Date: 2006-10-05 Impact factor: 3.603
Authors: Mohammed H Jamal; Suhail A R Doi; A James Moser; Sinziana Dumitra; Jad abou Khalil; Eve Simoneau; Prosanto Chaudhury; Adedayo A Onitilo; Peter Metrakos; Jeffrey S Barkun Journal: World J Gastroenterol Date: 2014-09-14 Impact factor: 5.742
Authors: Nicholas Zdenkowski; George Radvan; Leanna Pugliese; Julie Charlton; Christopher Oldmeadow; Allison Fraser; Antonino Bonaventura Journal: Support Care Cancer Date: 2017-02-04 Impact factor: 3.603
Authors: K Lombard; J van Steijn; T Schuur; M Kuhn; C Rouws; E-L Huinink; C van der Hooft; D van Asselt Journal: J Nutr Health Aging Date: 2014-07 Impact factor: 4.075